Exclusive agreements between Federal agencies and Bristol-Myers Squibb Co. for drug development [microform] : is the public interest protected? : hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, first session, Washington, DC, July 29, 1991.
United States.Congress.House.Committee on Small Business.Subcommittee on Regulation, Business Opportunities, and Energy.
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,
1992.
"Serial no. 102-35."
Includes bibliographical references.
Microfiche.
Bristol-Myers Squibb Company.
Drugs
Cancer
Exclusive contracts